These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1684 related items for PubMed ID: 19752319

  • 1. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH, ATHENA Investigators.
    Circulation; 2009 Sep 29; 120(13):1174-80. PubMed ID: 19752319
    [Abstract] [Full Text] [Related]

  • 2. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
    Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Petersen C.
    J Cardiovasc Electrophysiol; 2008 Jan 29; 19(1):69-73. PubMed ID: 18031520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH, EURIDIS and ADONIS Investigators.
    N Engl J Med; 2007 Sep 06; 357(10):987-99. PubMed ID: 17804843
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial.
    Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A.
    Am J Ther; 2014 Sep 06; 21(6):500-8. PubMed ID: 23344106
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Expert Opin Drug Saf; 2010 Jan 06; 9(1):189-99. PubMed ID: 20001756
    [Abstract] [Full Text] [Related]

  • 10. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM, Herold M, Hoglund C, Timmermans A, Alings A, Radzik D, Van Kempen L, ERATO Study Investigators.
    Am Heart J; 2008 Sep 06; 156(3):527.e1-9. PubMed ID: 18760136
    [Abstract] [Full Text] [Related]

  • 11. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
    Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL.
    Clin Cardiol; 2010 May 06; 33(5):270-9. PubMed ID: 20513065
    [Abstract] [Full Text] [Related]

  • 12. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT, Ehrlich JR, Hohnloser SH.
    J Cardiovasc Electrophysiol; 2006 Sep 06; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [Abstract] [Full Text] [Related]

  • 13. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ, Schmitt J, Hohnloser SH.
    J Cardiovasc Pharmacol Ther; 2010 Dec 06; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [Abstract] [Full Text] [Related]

  • 14. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM, White CM.
    Ann Pharmacother; 2007 Apr 06; 41(4):599-605. PubMed ID: 17389667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF.
    J Am Coll Cardiol; 2009 Sep 15; 54(12):1089-95. PubMed ID: 19744618
    [Abstract] [Full Text] [Related]

  • 18. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Litinski I, Simantov R, Moshkovitz Y, Zaidenstein R, Peleg E, Vered Z, Golik A.
    Eur Heart J; 1999 Dec 15; 20(24):1833-42. PubMed ID: 10581142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.